Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888443845> ?p ?o ?g. }
- W2888443845 endingPage "1153" @default.
- W2888443845 startingPage "1153" @default.
- W2888443845 abstract "Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid infiltration of the liver, highly prevalent in the general population affecting 25% of adults, with a doubled prevalence in diabetic and obese patients. Almost 1/3 of NAFLD evolves in Non-Alcoholic SteatoHepatitis (NASH), and this can lead to fibrosis and cirrhosis of the liver. However, the main causes of mortality of patients with NAFLD are cardiovascular diseases. At present, there are no specific drugs approved on the market for the treatment of NAFLD, and the treatment is essentially based on optimization of lifestyle. However, some nutraceuticals could contribute to the improvement of lipid infiltration of the liver and of the related anthropometric, haemodynamic, and/or biochemical parameters. The aim of this paper is to review the available clinical data on the effect of nutraceuticals on NAFLD and NAFLD-related parameters. Relatively few nutraceutical molecules have been adequately studied for their effects on NAFLD. Among these, we have analysed in detail the effects of silymarin, vitamin E, vitamin D, polyunsaturated fatty acids of the omega-3 series, astaxanthin, coenzyme Q10, berberine, curcumin, resveratrol, extracts of Salvia milthiorriza, and probiotics. In conclusion, Silymarin, vitamin E and vitamin D, polyunsaturated fatty acids of the omega-3 series, coenzyme Q10, berberine and curcumin, if well dosed and administered for medium⁻long periods, and associated to lifestyle changes, could exert positive effects on NAFLD and NAFLD-related parameters." @default.
- W2888443845 created "2018-08-31" @default.
- W2888443845 creator A5046258505 @default.
- W2888443845 creator A5068440626 @default.
- W2888443845 creator A5080216454 @default.
- W2888443845 date "2018-08-23" @default.
- W2888443845 modified "2023-09-30" @default.
- W2888443845 title "Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence" @default.
- W2888443845 cites W1524101974 @default.
- W2888443845 cites W1565527343 @default.
- W2888443845 cites W1696896561 @default.
- W2888443845 cites W179306699 @default.
- W2888443845 cites W1877431291 @default.
- W2888443845 cites W1914169609 @default.
- W2888443845 cites W1970224691 @default.
- W2888443845 cites W1980245616 @default.
- W2888443845 cites W1985583116 @default.
- W2888443845 cites W1998009398 @default.
- W2888443845 cites W2000252537 @default.
- W2888443845 cites W2003563978 @default.
- W2888443845 cites W2006933971 @default.
- W2888443845 cites W2021112085 @default.
- W2888443845 cites W2030434750 @default.
- W2888443845 cites W2034604842 @default.
- W2888443845 cites W2036657821 @default.
- W2888443845 cites W2049471857 @default.
- W2888443845 cites W2057445384 @default.
- W2888443845 cites W2061555473 @default.
- W2888443845 cites W2069354135 @default.
- W2888443845 cites W2080835467 @default.
- W2888443845 cites W2083373216 @default.
- W2888443845 cites W2090967456 @default.
- W2888443845 cites W2111946630 @default.
- W2888443845 cites W2127030655 @default.
- W2888443845 cites W2132141016 @default.
- W2888443845 cites W2142110193 @default.
- W2888443845 cites W2149697993 @default.
- W2888443845 cites W2153068313 @default.
- W2888443845 cites W2156224448 @default.
- W2888443845 cites W2166004879 @default.
- W2888443845 cites W2170538102 @default.
- W2888443845 cites W2173257315 @default.
- W2888443845 cites W2190145122 @default.
- W2888443845 cites W2211572047 @default.
- W2888443845 cites W2278355670 @default.
- W2888443845 cites W2298528870 @default.
- W2888443845 cites W2317517999 @default.
- W2888443845 cites W2339083408 @default.
- W2888443845 cites W2340190976 @default.
- W2888443845 cites W2344461043 @default.
- W2888443845 cites W2344665524 @default.
- W2888443845 cites W2346495725 @default.
- W2888443845 cites W2396689418 @default.
- W2888443845 cites W2398606076 @default.
- W2888443845 cites W2399995929 @default.
- W2888443845 cites W2411894854 @default.
- W2888443845 cites W2418362421 @default.
- W2888443845 cites W2429102024 @default.
- W2888443845 cites W2436950019 @default.
- W2888443845 cites W2466890750 @default.
- W2888443845 cites W2509952385 @default.
- W2888443845 cites W2514499016 @default.
- W2888443845 cites W2523429191 @default.
- W2888443845 cites W2524984873 @default.
- W2888443845 cites W2525906202 @default.
- W2888443845 cites W2528632550 @default.
- W2888443845 cites W2529199188 @default.
- W2888443845 cites W2567030468 @default.
- W2888443845 cites W2567124592 @default.
- W2888443845 cites W2568092152 @default.
- W2888443845 cites W2580291574 @default.
- W2888443845 cites W2588311599 @default.
- W2888443845 cites W2740563274 @default.
- W2888443845 cites W2745865165 @default.
- W2888443845 cites W2753463653 @default.
- W2888443845 cites W2760808255 @default.
- W2888443845 cites W2762994022 @default.
- W2888443845 cites W2766972897 @default.
- W2888443845 cites W2767917689 @default.
- W2888443845 cites W2769691827 @default.
- W2888443845 cites W2773601938 @default.
- W2888443845 cites W2775135060 @default.
- W2888443845 cites W2779319743 @default.
- W2888443845 cites W2780477102 @default.
- W2888443845 cites W2788119666 @default.
- W2888443845 cites W2791625216 @default.
- W2888443845 cites W2791880774 @default.
- W2888443845 cites W2791899259 @default.
- W2888443845 cites W2794304138 @default.
- W2888443845 cites W2794687660 @default.
- W2888443845 cites W2795361822 @default.
- W2888443845 cites W2796128011 @default.
- W2888443845 cites W2801991651 @default.
- W2888443845 cites W2802778144 @default.
- W2888443845 cites W2803151742 @default.
- W2888443845 cites W2803491661 @default.
- W2888443845 cites W2964858684 @default.
- W2888443845 cites W3021842026 @default.